| Literature DB >> 28081550 |
Klaus Kaae Andersen1, Anne Katrine Duun-Henriksen1, Marie Hoffmann Frederiksen1, Jeanette Falck Winther2.
Abstract
BACKGROUND: Childhood cancer survivors can experience learning problems resulting in lower-than-expected attained education as adults. It is unclear whether learning problems manifest already during adolescence.Entities:
Mesh:
Year: 2017 PMID: 28081550 PMCID: PMC5294489 DOI: 10.1038/bjc.2016.438
Source DB: PubMed Journal: Br J Cancer ISSN: 0007-0920 Impact factor: 7.640
Characteristics of the children included in the study stratified by childhood cancer status (background vs childhood cancer survivors)
| Age mean (s.d.) | 15.24 (0.44) | 15.32 (0.48) | ||
| Gender (%) | ||||
| Male | 398 168 (50.3) | 689 (52.2) | ||
| Female | 393 844 (49.7) | 631 (47.8) | ||
| Birth year (%) | ||||
| Before 1990 | 284 775 (36.0) | 503 (38.1) | ||
| (1990,1995) | 323 875 (40.9) | 498 (37.7) | ||
| After 1995 | 183 362 (23.2) | 319 (24.2) | ||
| Age at diagnosis (%) | ||||
| Between 0 and 2 | 199 (15.1) | |||
| Between 2 and 5 | 326 (24.7) | |||
| Between 5 and 10 | 332 (25.2) | |||
| Between 10 and 15 | 463 (35.1) | |||
| Cancer site | ||||
| Leukaemia | 417 (31.6) | 96.3 | 77.2 | |
| Lymphomas | 158 (12.0) | 94.6 | 87.4 | |
| CNS tumour | 269 (20.4) | 72.9 | 68.7 | |
| Neuroblastoma | 54 (4.1) | 100 | 50.0 | |
| Retinoblastoma | 55 (4.2) | 100 | 98.2 | |
| Renal tumour | 75 (5.7) | 93.4 | 87.0 | |
| Hepatic tumour | 14 (1.1) | 93.3 | 68.2 | |
| Bone tumour | 62 (4.7) | 100 | 53.3 | |
| Soft tissue sarcoma | 70 (5.3) | 94.5 | 63.8 | |
| Germ-cell tumour | 38 (2.9) | 79.1 | 80.0 | |
| Malignant epithelial tumour | 93 (7.0) | 97.9 | 92.2 | |
| Other malignant neoplasm | 15 (1.1) | 93.7 | 88.9 |
Abbreviation: CNS=central nervous system.
The mean of rank grades by grade categories, and Pearson correlation between grade categories for both background and survivors
| All subjects | 0.50 | 0.48 | 0.002 | |||||
| Math o/w | 0.50 | 0.47 | 0.69/0.68 | 0.57/057 | 0.59/0.57 | |||
| Danish o/w | 0.50 | 0.48 | 0.012 | 0.73/0.72 | 0.69/0.66 | |||
| English o/w | 0.50 | 0.48 | 0.004 | 0.59/0.55 | ||||
| Language o | 0.50 | 0.48 | 0.074 | |||||
| National test | 0.50 | 0.48 | 0.017 | 0.86/0.83 | ||||
| Teacher evaluation | 0.50 | 0.47 | 0.001 | |||||
| Written | 0.50 | 0.48 | 0.007 | 0.85/0.84 | ||||
| Oral | 0.50 | 0.48 | 0.015 | |||||
Abbreviations: o=oral; w=written.
As some grade categories include the same school subjects (e.g., grades in written tests also include grades in mathematics), only the correlation between categories that includes disjoint subjects are shown.
The mean rank grades by cancer site, age at diagnosis and birth year for childhood cancer survivors
| Background | 792 012 | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 |
| Cancer Site | ||||||||||
| Leukaemia | 417 | 0.47 | 0.47 | 0.47 | 0.48 | 0.49 | 0.47 | 0.47 | 0.47 | 0.48 |
| Lymphomas | 158 | 0.45 | 0.46 | 0.46 | 0.48 | 0.44 | 0.48 | 0.45 | 0.46 | 0.46 |
| CNS tumour | 269 | 0.44 | 0.44 | 0.44 | 0.42 | 0.46 | 0.44 | 0.43 | 0.44 | 0.44 |
| Neuroblastoma | 54 | 0.45 | 0.46 | 0.45 | 0.48 | 0.45 | 0.49 | 0.42 | 0.45 | 0.47 |
| Restinoblastoma | 55 | 0.54 | 0.57 | 0.54 | 0.51 | 0.51 | 0.55 | 0.54 | 0.55 | 0.54 |
| Renal tumour | 75 | 0.53 | 0.49 | 0.55 | 0.50 | 0.53 | 0.53 | 0.52 | 0.51 | 0.53 |
| Hepatic tumour | 14 | 0.50 | 0.48 | 0.53 | 0.49 | 0.51 | 0.49 | 0.50 | 0.52 | 0.49 |
| Bone tumour | 62 | 0.56 | 0.51 | 0.54 | 0.52 | 0.65 | 0.53 | 0.58 | 0.55 | 0.56 |
| Soft-tissue sarcoma | 70 | 0.54 | 0.52 | 0.54 | 0.53 | 0.52 | 0.58 | 0.51 | 0.52 | 0.54 |
| Germ-cell tumour | 38 | 0.48 | 0.49 | 0.47 | 0.46 | 0.48 | 0.48 | 0.49 | 0.49 | 0.49 |
| Malig. epithelial | 93 | 0.51 | 0.48 | 0.52 | 0.51 | 0.53 | 0.50 | 0.53 | 0.53 | 0.52 |
| Other malig. neoplasm | 15 | 0.43 | 0.40 | 0.43 | 0.47 | 0.47 | 0.41 | 0.44 | 0.44 | 0.44 |
| Age at diagnosis | ||||||||||
| Between 0 and 2 | 199 | 0.45 | 0.43 | 0.47 | 0.47 | 0.48 | 0.45 | 0.46 | 0.45 | 0.46 |
| Between 2 and 5 | 326 | 0.47 | 0.47 | 0.47 | 0.46 | 0.49 | 0.46 | 0.47 | 0.48 | 0.47 |
| Between 5 and 10 | 332 | 0.46 | 0.46 | 0.46 | 0.47 | 0.47 | 0.47 | 0.46 | 0.46 | 0.48 |
| Between 10 and 15 | 463 | 0.50 | 0.49 | 0.50 | 0.51 | 0.49 | 0.51 | 0.50 | 0.51 | 0.50 |
| Birth year | ||||||||||
| Before 1990 | 503 | 0.48 | 0.47 | 0.48 | 0.48 | 0.48 | 0.49 | 0.48 | 0.48 | 0.48 |
| (1990,1995) | 498 | 0.48 | 0.46 | 0.49 | 0.48 | 0.48 | 0.49 | 0.47 | 0.48 | 0.48 |
| After 1995 | 319 | 0.47 | 0.49 | 0.47 | 0.47 | 0.47 | 0.48 | 0.47 | 0.47 | 0.49 |
Abbreviations: Eval=evaluation; Lang.=language; Malig.=malignant; o=oral; sub.=subject; w=written.
Figure 1Effect on overall rank grade by gender and cancer site. The vertical line at 50% represents no effect.
Figure 2Effect on overall rank grade by age at diagnosis and cancer site. Effect on overall rank grade by age at diagnosis for (I) leukemia (top left); (II) lymphoma (top right; (III) CNS (bottom left) and (IV–XII) other cancer sites (bottom right). The horizontal line at 50% represents no effect.